J&J Unit Slammed With $70M Verdict In Philly Risperdal Trial
By Matt Fair ( July 1, 2016, 1:20 PM EDT) -- A Johnson & Johnson unit was slapped with a $70 million verdict on Friday as a Philadelphia jury found that the antipsychotic drug Risperdal had caused an adolescent boy to grow female breasts....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.